HEADER PROTEIN TRANSPORT/MEMBRANE PROTEIN 29-DEC-10 3Q5U TITLE A MINIMAL NLS FROM HUMAN SCRAMBLASE 4 COMPLEXED WITH IMPORTIN ALPHA COMPND MOL_ID: 1; COMPND 2 MOLECULE: IMPORTIN SUBUNIT ALPHA-2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 70-529; COMPND 5 SYNONYM: IMPORTIN ALPHA P1, KARYOPHERIN SUBUNIT ALPHA-2, PENDULIN, COMPND 6 PORE TARGETING COMPLEX 58 KDA SUBUNIT, PTAC58, RAG COHORT PROTEIN 1, COMPND 7 SRP1-ALPHA; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: PHOSPHOLIPID SCRAMBLASE 4; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: UNP RESIDUES 271-283; COMPND 13 SYNONYM: PL SCRAMBLASE 4, CA(2+)-DEPENDENT PHOSPHOLIPID SCRAMBLASE 4, COMPND 14 CELL GROWTH-INHIBITING GENE 43 PROTEIN, TRA1; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: KPNA2, RCH1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-30A; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: HUMAN PLSCR4-NLS WAS SYNTHESIZED BY SOLID-PHASE SOURCE 14 METHODS AND PURIFIED BY REVERSE-PHASE HPLC (M.W. 1483.78 DALTONS) KEYWDS ARMADILLO REPEAT, PROTEIN TRANSPORT, PROTEIN TRANSPORT-MEMBRANE KEYWDS 2 PROTEIN COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.BHARDWAJ,G.CINGOLANI REVDAT 6 13-SEP-23 3Q5U 1 REMARK REVDAT 5 07-MAR-18 3Q5U 1 REMARK REVDAT 4 08-NOV-17 3Q5U 1 REMARK REVDAT 3 24-AUG-11 3Q5U 1 JRNL REVDAT 2 20-JUL-11 3Q5U 1 JRNL REVDAT 1 29-JUN-11 3Q5U 0 JRNL AUTH K.LOTT,A.BHARDWAJ,P.J.SIMS,G.CINGOLANI JRNL TITL A MINIMAL NUCLEAR LOCALIZATION SIGNAL (NLS) IN HUMAN JRNL TITL 2 PHOSPHOLIPID SCRAMBLASE 4 THAT BINDS ONLY THE MINOR JRNL TITL 3 NLS-BINDING SITE OF IMPORTIN {ALPHA}1. JRNL REF J.BIOL.CHEM. V. 286 28160 2011 JRNL REFN ISSN 0021-9258 JRNL PMID 21690087 JRNL DOI 10.1074/JBC.M111.228007 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.6.3_473) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.81 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.9 REMARK 3 NUMBER OF REFLECTIONS : 22316 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 1127 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.8122 - 4.9931 1.00 3036 160 0.1782 0.1906 REMARK 3 2 4.9931 - 3.9662 1.00 2898 159 0.1446 0.1669 REMARK 3 3 3.9662 - 3.4657 1.00 2896 145 0.1647 0.2076 REMARK 3 4 3.4657 - 3.1492 0.99 2824 152 0.1998 0.2497 REMARK 3 5 3.1492 - 2.9237 0.98 2806 151 0.1959 0.2440 REMARK 3 6 2.9237 - 2.7514 0.96 2712 139 0.2132 0.2769 REMARK 3 7 2.7514 - 2.6137 0.80 2268 123 0.2502 0.2862 REMARK 3 8 2.6137 - 2.5000 0.62 1749 98 0.3006 0.3995 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.20 REMARK 3 SHRINKAGE RADIUS : 0.95 REMARK 3 K_SOL : 0.37 REMARK 3 B_SOL : 30.45 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.330 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.060 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 38.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.09930 REMARK 3 B22 (A**2) : -2.18700 REMARK 3 B33 (A**2) : 0.08780 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 3354 REMARK 3 ANGLE : 1.092 4568 REMARK 3 CHIRALITY : 0.083 549 REMARK 3 PLANARITY : 0.004 584 REMARK 3 DIHEDRAL : 15.276 1227 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 75.8842 68.7668 48.7350 REMARK 3 T TENSOR REMARK 3 T11: 0.0076 T22: 0.0300 REMARK 3 T33: 0.0106 T12: 0.0099 REMARK 3 T13: 0.0271 T23: -0.0308 REMARK 3 L TENSOR REMARK 3 L11: 0.1898 L22: 0.1363 REMARK 3 L33: 0.1059 L12: 0.1489 REMARK 3 L13: 0.1221 L23: 0.1120 REMARK 3 S TENSOR REMARK 3 S11: 0.0208 S12: 0.0797 S13: -0.0497 REMARK 3 S21: 0.0009 S22: 0.0611 S23: -0.0351 REMARK 3 S31: -0.0247 S32: 0.0287 S33: 0.1868 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT USING RIGID BODY REFINEMENT, REMARK 3 SIMULATED ANNEALING AND ISOTROPIC B-FACTOR IN PHENIX REMARK 4 REMARK 4 3Q5U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-DEC-10. REMARK 100 THE DEPOSITION ID IS D_1000063231. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-AUG-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : SEALED TUBE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : OXFORD DIFFRACTION ENHANCE ULTRA REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5 REMARK 200 MONOCHROMATOR : MIRROR REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : OXFORD ONYX CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22733 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.4 REMARK 200 DATA REDUNDANCY : 7.500 REMARK 200 R MERGE (I) : 0.17100 REMARK 200 R SYM (I) : 0.15900 REMARK 200 FOR THE DATA SET : 12.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 67.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.77300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLECULAR REPLACEMENT USING PHASER REMARK 200 STARTING MODEL: PDB CODE 1Y2A REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.3 UL OF DELTAIBB-IMPORTIN ALPHA REMARK 280 CONCENTRATED TO 20 MG/ML WERE MIXED WITH 0.7 MICROLITRE OF A 2- REMARK 280 FOLD MOLAR EXCESS OF HPLSCR4-NLS PEPTIDE; 3 UL OF RESERVOIR REMARK 280 SOLUTION CONTAINING ~0.8 M SODIUM CITRATE, 100 MM HEPES, AND 10 REMARK 280 MM BETA-MERCAPTOETHANOL WERE ADDED TO THE DROP, PH 6.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 38.72550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.44750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.48650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.44750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 38.72550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.48650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: MONOMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 70 REMARK 465 GLN A 71 REMARK 465 GLY A 72 REMARK 465 THR A 73 REMARK 465 VAL A 74 REMARK 465 VAL A 498 REMARK 465 GLU A 499 REMARK 465 GLU A 500 REMARK 465 GLU A 501 REMARK 465 GLU A 502 REMARK 465 ASP A 503 REMARK 465 GLN A 504 REMARK 465 ASN A 505 REMARK 465 VAL A 506 REMARK 465 VAL A 507 REMARK 465 PRO A 508 REMARK 465 GLU A 509 REMARK 465 THR A 510 REMARK 465 THR A 511 REMARK 465 SER A 512 REMARK 465 GLU A 513 REMARK 465 GLY A 514 REMARK 465 PHE A 515 REMARK 465 ALA A 516 REMARK 465 PHE A 517 REMARK 465 GLN A 518 REMARK 465 VAL A 519 REMARK 465 GLN A 520 REMARK 465 ASP A 521 REMARK 465 GLY A 522 REMARK 465 ALA A 523 REMARK 465 PRO A 524 REMARK 465 GLY A 525 REMARK 465 THR A 526 REMARK 465 PHE A 527 REMARK 465 ASN A 528 REMARK 465 PHE A 529 REMARK 465 ASN B 271 REMARK 465 ILE B 272 REMARK 465 GLY B 281 REMARK 465 LEU B 282 REMARK 465 LEU B 283 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 239 156.87 89.38 REMARK 500 TRP B 279 -152.89 -175.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LYS B 278 TRP B 279 100.16 REMARK 500 TRP B 279 ASN B 280 139.63 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1Y2A RELATED DB: PDB REMARK 900 STRUCTURE OF MAMMALIAN IMPORTIN BOUND TO THE NON-CLASSICAL PLSCR1- REMARK 900 NLS DBREF 3Q5U A 70 529 UNP P52293 IMA2_MOUSE 70 529 DBREF 3Q5U B 271 283 UNP Q9NRQ2 PLS4_HUMAN 271 283 SEQRES 1 A 460 ASN GLN GLY THR VAL ASN TRP SER VAL GLU ASP ILE VAL SEQRES 2 A 460 LYS GLY ILE ASN SER ASN ASN LEU GLU SER GLN LEU GLN SEQRES 3 A 460 ALA THR GLN ALA ALA ARG LYS LEU LEU SER ARG GLU LYS SEQRES 4 A 460 GLN PRO PRO ILE ASP ASN ILE ILE ARG ALA GLY LEU ILE SEQRES 5 A 460 PRO LYS PHE VAL SER PHE LEU GLY LYS THR ASP CYS SER SEQRES 6 A 460 PRO ILE GLN PHE GLU SER ALA TRP ALA LEU THR ASN ILE SEQRES 7 A 460 ALA SER GLY THR SER GLU GLN THR LYS ALA VAL VAL ASP SEQRES 8 A 460 GLY GLY ALA ILE PRO ALA PHE ILE SER LEU LEU ALA SER SEQRES 9 A 460 PRO HIS ALA HIS ILE SER GLU GLN ALA VAL TRP ALA LEU SEQRES 10 A 460 GLY ASN ILE ALA GLY ASP GLY SER ALA PHE ARG ASP LEU SEQRES 11 A 460 VAL ILE LYS HIS GLY ALA ILE ASP PRO LEU LEU ALA LEU SEQRES 12 A 460 LEU ALA VAL PRO ASP LEU SER THR LEU ALA CYS GLY TYR SEQRES 13 A 460 LEU ARG ASN LEU THR TRP THR LEU SER ASN LEU CYS ARG SEQRES 14 A 460 ASN LYS ASN PRO ALA PRO PRO LEU ASP ALA VAL GLU GLN SEQRES 15 A 460 ILE LEU PRO THR LEU VAL ARG LEU LEU HIS HIS ASN ASP SEQRES 16 A 460 PRO GLU VAL LEU ALA ASP SER CYS TRP ALA ILE SER TYR SEQRES 17 A 460 LEU THR ASP GLY PRO ASN GLU ARG ILE GLU MET VAL VAL SEQRES 18 A 460 LYS LYS GLY VAL VAL PRO GLN LEU VAL LYS LEU LEU GLY SEQRES 19 A 460 ALA THR GLU LEU PRO ILE VAL THR PRO ALA LEU ARG ALA SEQRES 20 A 460 ILE GLY ASN ILE VAL THR GLY THR ASP GLU GLN THR GLN SEQRES 21 A 460 LYS VAL ILE ASP ALA GLY ALA LEU ALA VAL PHE PRO SER SEQRES 22 A 460 LEU LEU THR ASN PRO LYS THR ASN ILE GLN LYS GLU ALA SEQRES 23 A 460 THR TRP THR MET SER ASN ILE THR ALA GLY ARG GLN ASP SEQRES 24 A 460 GLN ILE GLN GLN VAL VAL ASN HIS GLY LEU VAL PRO PHE SEQRES 25 A 460 LEU VAL GLY VAL LEU SER LYS ALA ASP PHE LYS THR GLN SEQRES 26 A 460 LYS GLU ALA ALA TRP ALA ILE THR ASN TYR THR SER GLY SEQRES 27 A 460 GLY THR VAL GLU GLN ILE VAL TYR LEU VAL HIS CYS GLY SEQRES 28 A 460 ILE ILE GLU PRO LEU MET ASN LEU LEU SER ALA LYS ASP SEQRES 29 A 460 THR LYS ILE ILE GLN VAL ILE LEU ASP ALA ILE SER ASN SEQRES 30 A 460 ILE PHE GLN ALA ALA GLU LYS LEU GLY GLU THR GLU LYS SEQRES 31 A 460 LEU SER ILE MET ILE GLU GLU CYS GLY GLY LEU ASP LYS SEQRES 32 A 460 ILE GLU ALA LEU GLN ARG HIS GLU ASN GLU SER VAL TYR SEQRES 33 A 460 LYS ALA SER LEU ASN LEU ILE GLU LYS TYR PHE SER VAL SEQRES 34 A 460 GLU GLU GLU GLU ASP GLN ASN VAL VAL PRO GLU THR THR SEQRES 35 A 460 SER GLU GLY PHE ALA PHE GLN VAL GLN ASP GLY ALA PRO SEQRES 36 A 460 GLY THR PHE ASN PHE SEQRES 1 B 13 ASN ILE GLY SER ILE ILE ARG LYS TRP ASN GLY LEU LEU FORMUL 3 HOH *191(H2 O) HELIX 1 1 SER A 77 SER A 87 1 11 HELIX 2 2 ASN A 89 LEU A 104 1 16 HELIX 3 3 PRO A 111 ALA A 118 1 8 HELIX 4 4 GLY A 119 LEU A 128 1 10 HELIX 5 5 CYS A 133 SER A 149 1 17 HELIX 6 6 THR A 151 GLY A 161 1 11 HELIX 7 7 GLY A 162 LEU A 171 1 10 HELIX 8 8 HIS A 175 GLY A 191 1 17 HELIX 9 9 GLY A 193 HIS A 203 1 11 HELIX 10 10 ALA A 205 LEU A 212 1 8 HELIX 11 11 ASP A 217 LEU A 221 5 5 HELIX 12 12 ALA A 222 LEU A 236 1 15 HELIX 13 13 PRO A 245 HIS A 261 1 17 HELIX 14 14 ASP A 264 THR A 279 1 16 HELIX 15 15 PRO A 282 LYS A 291 1 10 HELIX 16 16 VAL A 294 GLY A 303 1 10 HELIX 17 17 GLU A 306 VAL A 321 1 16 HELIX 18 18 THR A 324 ALA A 334 1 11 HELIX 19 19 GLY A 335 ALA A 338 5 4 HELIX 20 20 VAL A 339 LEU A 344 1 6 HELIX 21 21 LYS A 348 ALA A 364 1 17 HELIX 22 22 ARG A 366 HIS A 376 1 11 HELIX 23 23 GLY A 377 LYS A 388 1 12 HELIX 24 24 ASP A 390 GLY A 408 1 19 HELIX 25 25 THR A 409 CYS A 419 1 11 HELIX 26 26 ILE A 421 LEU A 429 1 9 HELIX 27 27 ASP A 433 LYS A 453 1 21 HELIX 28 28 GLU A 456 CYS A 467 1 12 HELIX 29 29 GLY A 468 LEU A 476 1 9 HELIX 30 30 GLN A 477 HIS A 479 5 3 HELIX 31 31 ASN A 481 PHE A 496 1 16 CISPEP 1 ASN A 241 PRO A 242 0 3.20 CISPEP 2 GLY B 273 SER B 274 0 -2.63 CRYST1 77.451 90.973 96.895 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012911 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010992 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010320 0.00000